ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO505

Deletion of Peroxisome-Proliferator-Activated Receptor δ in Mice Promotes High-Fat-Diet-Induced Renal Injury

Session Information

Category: Diabetic Kidney Disease

  • 601 Diabetic Kidney Disease: Basic

Authors

  • You, Yongke, The Chinese University of HongKong, Hong Kong, China
  • Chen, Hai-Yong, The University of Hong Kong, Hong Kong, China
  • Huang, Yu, The Chinese University of Hong Kong, Shatin, China
  • Lan, Hui Y., The Chinese University of HongKong, Hong Kong, China
Background

Peroxisome proliferator-activated receptor δ (PPARδ), the least studied member of the PPAR group in the nuclear receptor superfamily, plays a crucial role in cellular metabolic functions and other physiological processes. Recent evidence highlights the therapeutic potential of PPARδ agonists in obesity, dyslipidaemia, insulin resistance/type 2 diabetes. However, little is known the role of PPARδ in the pathogenesis of obesity related renal injury. It is reported that PPARδ gene is a primary target of 1a,25-dihydroxyvitamin D3 (calcitriol), the aim of this study is to investigate the effects of calcitriol on the role of PPARδ in HFD-induced renal injury.

Methods

Diet-induced obese (DIO) micewere generated on PPARδ KO, age-matched PPARδ wildtype (WT) littermates at the 6 weeks of age and were fed with high-fat-diet (HFD) for 12 weeks. In addition,12 weeks after HFD feeding, mice were treated with 1a,25-dihydroxyvitamin D3 (calcitriol) or vehicle by intraperitoneal injection at the dosage of 100 ng/kg three times a week for 4 weeks.The effects of calcitriol on the role of PPARδ in HFD-induced renal injury were evaluated by real-time quantitative polymerase-chain-reaction (qRT-PCR), western blot analysis, as well as a histological examination.

Results

Compared with control mice on a normal diet, DIO PPARδ WT mice exhibited significant renal injury, which were further exacerbated in DIO PPARδ KO mice: including 1) obviously increased expression of kidney injury molecule-1 (KIM-1),as well as histological injury revealed by Masson‘s Trichrome &PAS Staining; 2) marked up-regulation of pro-inflammatory cytokines TNF-a; 3) exacerbated renal fibrosis as demonstrated by significantly up-regulation of fibrotic matrix proteins deposition, such as a-smooth muscle actin (a-SMA) , collagen 1 and fibronectin. However, all these changes were dramatically attenuated after administration of calcitriol.

Conclusion

In conclusion, deletion of PPARδ promotes HFD-induced renal fibrosis and inflammation, and these changes could be partially attenuated by calcitriol treatment. Targeting PPARδ gene may offer a new treatment approach for obesity-related renal injury.